CARsgen Therapeutics Holdings Limited (2171.HK)

HKD 15.94

(2.57%)

Operating Expenses Summary of CARsgen Therapeutics Holdings Limited

  • CARsgen Therapeutics Holdings Limited's latest annual operating expenses in 2023 was 767.64 Million CNY , down -4.32% from previous year.
  • CARsgen Therapeutics Holdings Limited's latest quarterly operating expenses in 2024 Q2 was - CNY , down 0.0% from previous quarter.
  • CARsgen Therapeutics Holdings Limited reported a annual operating expenses of 802.28 Million CNY in annual operating expenses 2022, up 31.13% from previous year.
  • CARsgen Therapeutics Holdings Limited reported a annual operating expenses of 611.8 Million CNY in annual operating expenses 2021, up 75.47% from previous year.
  • CARsgen Therapeutics Holdings Limited reported a quarterly operating expenses of - CNY for 2024 Q1, down -100.0% from previous quarter.
  • CARsgen Therapeutics Holdings Limited reported a quarterly operating expenses of 219.98 Thousand CNY for 2023 Q2, down 0.0% from previous quarter.

Annual Operating Expenses Chart of CARsgen Therapeutics Holdings Limited (2023 - 2019)

Historical Annual Operating Expenses of CARsgen Therapeutics Holdings Limited (2023 - 2019)

Year Operating Expenses Operating Expenses Growth
2023 767.64 Million CNY -4.32%
2022 802.28 Million CNY 31.13%
2021 611.8 Million CNY 75.47%
2020 348.66 Million CNY 51.36%
2019 230.35 Million CNY 0.0%

Peer Operating Expenses Comparison of CARsgen Therapeutics Holdings Limited

Name Operating Expenses Operating Expenses Difference
Uni-Bio Science Group Limited 325.05 Million HKD -136.163%
CK Life Sciences Int'l., (Holdings) Inc. 739.25 Million HKD -3.841%